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ABSTRACT
Chronic non-specific low back pain (CLBP) is a common clinical condition that has impacts at both 
the individual and societal level. Pain intensity is a primary outcome used in clinical practice to 
quantify the severity of CLBP and the efficacy of its treatment, however, pain is a subjective 
experience that is impacted by a multitude of factors. Moreover, differences in effect sizes for pain 
intensity are not observed between common conservative treatments, such as spinal manipulative 
therapy, cognitive behavioural therapy, acupuncture and exercise training. As pain science evolves, 
the biopsychosocial model is gaining interest in its application for CLBP management. The aim of 
this paper is to discuss our current scientific understanding of pain and present why additional factors 
should be considered in conservative CLBP management. In addition to pain intensity, we 
recommend that clinicians should consider assessing the multidimensional nature of CLBP by 
including physical (disability, muscular strength and endurance, performance in activities of daily 
living and body composition), psychological (kinesiophobia, fear-avoidance, pain catastrophizing, 
pain self-efficacy, depression, anxiety and sleep quality), social (social functioning and work 
absenteeism) and health-related quality of life measures, depending on what is deemed relevant for 
each individual. This review also provides practical recommendations to clinicians for the assessment 
of outcomes beyond pain intensity, including information on how large a change must be for it to be 
considered ‘real’ in an individual patient. This information can guide treatment selection when 
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BACKGROUND
Low back pain (LBP) occurs in 40-85% of people at some point in their lives1,2 and remains the 
leading cause of reduced function and years lived with disability worldwide.3,4 Costs of LBP in the 
United States of America were shown to be as high as US$102 billion per year.5 Furthermore, a 
systematic review showed that up to 71% of individuals with acute LBP are not fully recovered after 
one year, which may contribute to the costs of the condition.6 Chronic LBP (CLBP) is defined as 
persistent pain for a period of greater than 12 weeks7 and affects approximately 20% of the global 
population.1 In CLBP, 85-90% of cases have pain that cannot be determined to arise from a definitive 
pathoanatomic structure or pathology,8 and is therefore termed ‘non-specific’.9 Specific pathologies 
that cause LBP include infections, metastasis/tumours, osteoporosis, inflammatory disorders, 
pregnancy, disc herniation and spinal stenosis for the minority of cases.9 Regarding types of pain, 
nociceptive pain arises from threatened or damaged tissue due to the activation of nociceptors, while 
neuropathic pain is considered to be caused by lesions in the somatosensory nervous system.10 
Nociceptive and neuropathic causes of pain can originate from specific spinal tissues, with various 
symptoms, such as the location of pain, numbness and tingling, aggravating and relieving movements, 
characterising different structures that are affected (e.g. facet joint syndrome, radicular pain and spinal 
stenosis).11 Moreover, nociplastic pain is defined as pain that is disproportionate to the LBP 
experience, barely related to spine movement or loading, and may or may not related to psychological 
factors.10 To avoid over-diagnosing non-specific CLBP, mechanism-based approaches have been 
previously suggested and could be followed clinically to help better determine specific nociceptive, 
neuropathic and nociplastic causes of pain.11,12
The management of non-specific CLBP is complicated by multi-dimensional contributions and 
consequences, including biological, psychological, and social factors.13 Conservative approaches, 
such as spinal manipulative therapy, cognitive behavioural therapy (CBT), pain neuroscience 
education (PNE), acupuncture and exercise training have shown some success for reducing pain 
intensity, but the magnitude of their effect remains modest.8 However, less emphasis has been placed 
on physical function, general deconditioning, social isolation and psychological distress, which are 
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factors that may influence pain intensity at the level of the central nervous system (CNS), (ii) to 
review the multiple domains affected in individuals with CLBP and (iii) propose outcome measures 
that capture each domain and highlight treatments that may impact these measures. 
FACTORS INFLUENCING PAIN
Pain is a distressing experience that fulfils a protective function essential for survival. It acts as a 
stimulus to modify behaviours that might be detrimental for tissue integrity and may inform an 
individual potential or actual tissue damage.16 Pain is also a personal, subjective experience that is 
influenced by genetic, sensory, psychological, emotional, cultural and social factors.16 The impact of 
such contextual factors can be seen in the pathophysiology of perceived acute pain intensity through 
both peripheral and central processes.17 Peripherally, nociceptors are depolarized by noxious stimuli 
(e.g. mechanical, thermal or chemical stimuli) and the information travels through afferent fibres to 
the dorsal horn of the spinal cord where the signal may undergo modulation before reaching the 
supraspinal centers.18 Multiple brain regions analyse the transmitted information from the periphery 
with respect to several aspects of the threat (e.g. sensory, awareness, memory, emotional) and 
depending on the context of the threat, the nociceptive stimuli can be perceived as pain of varying 
intensity.19 For instance, descending pathways can facilitate or inhibit the nociceptive information 
where descending pain modulation pathways lie.19 It is through this mechanism that pain is influenced 
by top down contextual and dynamic factors (e.g. perceived threat, anxiety, mood, pain-memories) 
which will determine the resulting pain experience.19 In contrast to acute pain where there is a clear 
protective role, the ongoing experience of pain, definitive of chronic pain conditions, has been 
suggested to reflect a mismatch between the information on the state of the tissues coming from the 
peripheral receptors (no acute tissue injury) and the central processing of these information (perceived 
pain reflecting threat to the tissues).20,21 Therefore, pain may move from being an appropriate 
protective response to becoming overprotective, or results from a heightened state of sensitivity 
unrelated to tissue pathology.20,21 Persistence of this state of enhanced sensitivity of the CNS pain 
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Both the peripheral (e.g. nociceptive terminal) and central nervous systems (e.g. spinal cord and 
brain) can undergo changes that increase their sensitivity (e.g. increasing synaptic strength via long-
term potentiation) so that the efficacy of pain processing and protective reactions can be enhanced 
(Figure 1).20 Peripherally, tissues (e.g. intervertebral discs) may be characterized by chronic 
inflammatory states which can increase nociceptive stimulus strength where synaptic terminals lie in 
individuals with CLBP.22 At the spinal cord, hypersensitivity is increased through pro-inflammatory 
cytokine release, astrocyte and glial cell activation, which can reduce inhibitory tone and increase 
synaptic efficiency of ascending nociceptive stimuli (e.g. wind-up mechanism).17 The presence of an 
increased wind-up phenomenon can be evaluated by temporal summation paradigms which use brief 
repetitive mechanical, thermal or electrical stimuli delivered 1–3 times per second for 5 to 10 
seconds.23 In the case of increased wind-up mechanism, the temporal pain response is increased from 
the first to last repetition.24 This process within the spinal cord may lead to dynamic changes in 
second order spinal neurons (e.g. dorsal horn) that could be important for the development and 
maintenance of central sensitization in CLBP.25 It is also believed that central sensitization provides 
an overarching frame-work to better understand the transition of large-scale brain network activity in 
acute to chronic pain.26 In acute or experimental pain conditions, the brain networks activated are 
those mostly involved in the processing of the sensory-discriminative nature of pain (e.g. 
somatosensory cortex), whereas in chronic pain, the activity shifts to the brain networks related to 
emotional processing (e.g. prefrontal cortex).26 These alterations affect the expression and experience 
of pain as a result of the interplay between physiological (e.g. motor, sensory, autonomic) and 
psychological (e.g. emotion, cognition, learning) systems.26,27 This may explain why behavioural 
consequences, such as cognitive and memory deficits, exist in people with CLBP.28 It is now widely 
recognised that the intensity of pain can be moderated by psychological factors arising through 
neurobiological pathways in CLBP, and that these factors influence disability and the response to 
treatment.29 Hence, there is an urgent need to increase the consideration of the multidimensionality of 
pain in the assessment and treatment of CLBP.
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CURRENT MANAGEMENT OVER FOCUSES ON PAIN INTENSITY
Clinical treatment guidelines highlight the importance of conservative treatments for individuals with 
non-specific CLBP.7 Conservative interventions, such as PNE,30 CBT,31 spinal manipulative therapy 
and various forms of exercise training have shown some success in treating CLBP.32  Pain intensity is 
a common outcome used in the treatment of CLBP in clinical practice and is quantified through self-
reported scales, such as the visual analogue scale (VAS).33 The VAS most commonly ranges from 0-
100mm, with higher scores indicating a greater pain intensity.33 A 20mm reduction in pain intensity 
on the VAS is considered a clinically meaningful change.33 Meta-analyses in CLBP show differences 
in pain intensity do not reach the clinically meaningful threshold when interventions are compared.8 
Therefore, clinicians and patients should consider basing their choice of conservative management on 
additional outcomes and mutually agreed goals.34 Clinical guidelines in CLBP have moved towards 
the biopsychosocial model, which may provide clinicians with some insights into additional domains 
to consider for their patients (Figure 2).35,36 Considering that various domains are impacted in CLBP, 
management could aim to target these outcomes in addition to reducing pain intensity.14 Therefore, 
after the patient is subjectively assessed for risk factors and goals, we propose that clinicians should 
select outcome measures which are relevant to the person they are treating, that can be easily 
administered in clinical practice settings and that capture the most important domains of the 
biopsychosocial model, including physical, psychological and social well-being (Table 1).37
<INSERT FIGURE 2 HERE>
<INSERT TABLE 1 HERE>
MULTIDIMENTIONAL ASSESSMENT OF CHRONIC LOW BACK PAIN
Biological and Functional Outcomes
Disability 
Disability due to CLBP is restriction performing activities of daily living (ADLs) and could be a more 
important reason for individuals to seek care than pain intensity.38 A meta-analysis showed highly 
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disability.38 Targeting self-reported disability due to LBP with treatment may help reduce the need to 
seek professional advice (e.g. physiotherapist, physical therapist or exercise physiologist),39 improve 
the ability of the individual to complete ADLs38 and subsequently reduce health care costs.40 
Furthermore, clinical guidelines recommend assessing disability should be the highest priority for 
clinicians.41 In addition to LBP disability measures, tools such as the Orebro musculoskeletal pain 
questionnaire42 and the Keele STarT Back Tool43 may also be used as an initial screening tool to 
predict long-term disability.42,43 As LBP is a key component contributing to the global burden of 
disability, self-reported measures of LBP disability and long-term disability prognosis should be 
considered when assessing the efficacy of CLBP treatments. 
Muscular Endurance and Strength
A meta-analysis suggested muscular endurance and strength to be physical factors associated with 
LBP.44 Individuals with CLBP often have reduced trunk muscle endurance and this may partially 
relate to the reduced physical capacity in this population.45 Cross-sectional research in nurses 
demonstrated that reduced trunk extension endurance is associated with lower work capacities.46,47 
Nurses with a full work capacity had a 77% higher trunk extension endurance compared to those with 
work modifications due to CLBP.47 Furthermore, a systematic review showed functional status and 
physical demands may be important prognostic factors impeding return to work in those with CLBP.48 
Even though causality between CLBP and muscle function cannot be determined, improving trunk 
muscle endurance may provide important training specificity as it closely relates to occupational 
demands.49 Periods of time away from work may lead to deconditioning towards work-related tasks, 
and therefore may need to be improved to assist with tasks completion and return to work.48 Adequate 
levels of trunk endurance and overall strength appear to assist with ADLs and could be a prognostic 
factor for return to work, and should be considered in those with CLBP with high physical 
requirements. 
Performance in Activities of Daily Living
Self-reported measures of disability may not reflect the daily functioning of an individual with 
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between each other,51 which may relate to the presence of psychological factors, such as depression, 
causing underestimations on self-report disability measures.52 Therefore, assessing self-reported and 
objective measures may be important to assess functional capacities for those with CLBP.51 However, 
some measures of performance testing (e.g. stair climbing) have been indicated to be poor at 
differentiating function between people with CLBP and healthy controls.53 Furthermore, the ability of 
these measures to track change over time has been questioned, which may relate to a ceiling effect in 
those who are not highly disabled.54 Performance battery tests could be reserved for those who are 
highly disabled and cannot perform maximal strength and endurance tests to provide applicable 
results. 54 Therefore, performance battery tests could be important to distinguish self-reported and 
objective physical function.
Adiposity
Individuals with CLBP often have an increased body fat percentage55 and body mass index (BMI),56 
which may modulate pain through peripheral sensitisation from increased systemic inflammation.57 
Furthermore, increased fat infiltration of paraspinal musculature (particularly the lumbar multifidus) 
has been observed in CLBP,58 and could be associated with an increased BMI.59 This association is 
important as changes to paraspinal muscle composition could compromise function of the muscles 
that control and support the low back.60,61 Whilst the exact mechanisms and causality are unknown, 
adults with CLBP are more likely to present with obesity related comorbidities, such coronary heart 
disease.62 Individuals with a higher BMI also have greater disability before and after treatment and it 
may have an important biomechanical influence on functional recovery in those with CLBP.63 For 
example, those with CLBP and a BMI >27kg/m2 have a 16% greater risk of remaining highly disabled 
at one-year.64 Therefore, body weight, BMI, waist and hip circumference and waist-to-hip ratio could 
be assessed in those who are overweight or obese patients with CLBP, particularly as an increased 
BMI is associated with functional impairments and increased co-morbidities.64 
Psychological Outcomes
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Kinesiophobia is defined as the fear of movement65 and interferes with the ability to complete ADLs 
in individuals with CLBP.66 A review showed individuals with disabling CLBP and high fear-
avoidance beliefs had a 2-fold worse prognosis at 1-year compared to low fear-avoidance beliefs.64 
Furthermore, evidence supports the notion that even in individuals without LBP, movements, such as 
bending, are feared and considered dangerous.67 Given that contextual factors play a role in disability, 
it is possible that fear of particular movements could add to disability, rather than deconditioning 
alone and could affect compliance to exercise training.66 The removal of fear barriers to movement 
may therefore be important in promoting resumption of ADLs and reduce disability.64,66 Assessing 
and treating kinesiophobia and fear avoidance during management of CLBP may be important to 
reduce fear and disability, which could subsequently maximise the participation in ADLs. 
Pain Catastrophizing 
Pain catastrophizing is a state of anxiety towards pain and plays an important factor in the fear-
avoidance model.13 Common beliefs are held that the low back is vulnerable and fragile, which may 
lead to higher catastrophizing when pain occurs in this location.68 Individuals with CLBP and high 
catastrophizing are 56% more likely to be disabled than those with low catastrophizing.69 
Furthermore, one study showed that pain catastrophizing may explain more variance in disability 
(28%), when compared to pain intensity (3%).70 Even though the regression model used in this study 
did not include other important factors, such as fear-avoidance, catastrophizing may still be better 
than pain intensity for explaining disability in individuals with CLBP.70 Reducing catastrophic 
thinking may therefore help reduce the burden of disability in individuals with CLBP which may 
increase engagement in ADLs. 
Pain Self-Efficacy 
Pain self-efficacy is another important psychological outcome to consider when treating patients with 
CLBP.71 Pain self-efficacy reflects an individual’s ability to engage with ADLs despite the presence 
of pain.72 Cross-sectional research of individuals with severe disability (measured on the Oswestry 
disability index) showed lower levels of pain self-efficacy when compared to those with mild-
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levels are more likely to return to work.74 Pain self-efficacy also tends to mediate the relationship 
between pain and disability more than fear-avoidance.71 As the course of pain intensity in CLBP 
fluctuates, it may be important to understand how the individual psychologically deals with times of 
high pain intensity and if they continue to engage in normal activities.75 Therefore, as pain self-
efficacy can be used to understand how individuals cope with setbacks (e.g. flare-ups) it forms a 
potential outcome for treating individuals with CLBP.
Depression and Anxiety 
Longitudinal evidence of large samples sizes (pooled n=2,767) showed a bidirectional relationship 
between LBP, depression and anxiety.76,77 Furthermore, an epidemiological study in 190,593 
community-dwelling adults showed a higher prevalence of depression (25%) and anxiety (19%) in 
people with CLBP.78 Mental health disorders may partially explain disability in those with CLBP79 
and could be an important factor for recovery from disabling back pain.64 Furthermore, a systematic 
review showed that depression and anxiety are barriers for treatment adherence in various chronic 
pain conditions.80 Given the higher prevalence of these conditions in individuals with CLBP, 
improving mental health may subsequently improve treatment adherence and effectiveness.80 For 
individuals with CLBP reporting symptoms of depression and anxiety, assessing and treating these 
factors may be important for functional recovery. 
Sleep Quality
Impairments to sleep are commonly reported in individuals with CLBP, with a 55% decrease in sleep 
quality observed in this population following an increase in pain.81 An epidemiological study showed 
CLBP patients to have a 2.4-fold increased risk of sleep problems.78 Furthermore, there is the 
potential for there to be a bidirectional relationship between pain and sleep quality in individuals with 
CLBP.82 For example, every 0.49 point (out of 10 on a visual analogue scale) decrease is sleep 
quality, pain upon waking is one-point higher on the VAS.82 Meanwhile, for every one-point increase 
in average day time pain intensity, there is a 0.20 point decrease in sleep quality.82 Moreover, 
disturbances to the quality of sleep in individuals with CLBP is moderately correlated (r=0.42) to 









This article is protected by copyright. All rights reserved
Assessing and restoring sleep quality in those with CLBP who report sleep impairments may be 
important for reducing disability in this population.
Social Outcomes
Social Functioning
Social functioning is considered as the individual’s ability to engage in social activities.84 A 
qualitative review showed that individuals living with LBP felt they struggled to meet social 
expectations, which may subsequently impact the social identity of the invididual.85 Particularly, 
engagement in domestic chores, valued recreational activities and work tasks are impacted in those 
with CLBP.85 A previous study showed significant, albeit modest, correlation between individual 
perceptions of physical health and level of social interaction.86 This is important as the context of the 
social environment may also be a potential mediator of pain and subsequent social impairment.87 It is 
possible this may lead to a loss of social identity and the perceptions of ability to perform tasks at 
home and work, therefore contributing to functional impairments,86 decreases in the health-related 
quality of life88 and presence of comorbidities, such as depression.89 If the client reports limitations to 
their social functioning, it is important to assess the impact of CLBP on social functioning to help 
reduce the risk of the individual losing their social identity. 
Work Absenteeism 
Disability from LBP is highest amongst those of working age and tends to decline after retirement age 
(i.e. 55yrs).13 Accommodating work-related outcomes may be important at both an individual and 
economic level, as majority of the costs of LBP come from indirect sources, such as work 
absenteeism and early retirement.90 Previous work absenteeism due to LBP has been linked to a 31% 
less chance of functional recovery in those with CLBP,91 which may be associated with early 
retirement from low back issues.92 Early retirement due to LBP may lead to lower net wealth than 
counterparts who do not retire early, causing greater financial stress later in life.92 Reducing work 
absenteeism may be an important outcome measure to maximise functional work limitations and 
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Health-related Quality of Life
Quality of life is the self-evaluation of well-being and functioning by an individual.93 CLBP has a 
negative impact on the quality of life of an individual, particularly through perceptions of physical 
and mental health.88 A cross-sectional study in 1,208 pain clinic patients showed that individuals with 
CLBP had a lower quality of life compared to other chronic pain conditions, such as headaches and 
neck pain, as well as the general population.88 Importantly, improvements in quality of life may be 
dictated to a greater extent by disability and psychological improvements rather than pain 
intensity.94,95 Common quality of life questionnaires can measure varying domains including physical 
functioning, role limitations due to physical functioning, bodily pain, general health perception, 
vitality, social functioning, role limitations due to emotional and mental health.96 Measuring quality of 
life may provide insight into varying domains impacted in the individual and therefore allow targeted 
treatment to improve these. Pain intensity is not synonymous with the quality of life, therefore, 
assessing domains of quality of life may be important to discriminate treatment approaches and 
determine important client related goals in those with CLBP.
Integrating technological advances into outcomes
Technological advances should be considered by clinicians for the provision of outcomes during 
treatment of CLBP. Self-management applications have been used in CLBP, which could be used as 
outcomes or to attain intervention adherence.97 For example, fitness applications (with or without the 
use of a smartwatch) could be used to track daily physical activity and exercise progressions,98 weight 
loss,99 diet and nutrition,100 mood101 and sleep quality.102 The utility of such applications could be 
used to quantify day-to-day or week-to-week results of various outcomes, rather than being solely 
collected at periods where the individual reports back to their health care provider.103 As multiple 
areas can be assessed, it is important to determine the most relevant outcome domain for the 
individual when selecting which application to utilise.103 Therefore, these technologies should be 
considered alongside standard clinical measures (e.g. functional tests and questionnaires) to 
potentially provide better tracking of outcome measures for individuals with CLBP.
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Multiple domains and outcomes can be assessed in a patient with CLBP, therefore the clinician should 
select outcomes based off impacted areas and additional goals.104 Clinicians should engage in 
dialogue and listen to their patients to identify the most important clinical outcome measures, outside 
of pain intensity, for their patient.104 This may assist with determining the most appropriate 
intervention to reduce disability and improve quality of life in this population.104 Furthermore, 
technological advances (e.g. mobile applications) could be used to assist in the provision of outcome 
measures and could be utilised for an individual with CLBP.103 Given the wide range of measures 
possible to target, pending what outcomes are deemed relevant for the individual with CLBP, a 
multidisciplinary approach may best be utilised to maximise outcomes.
A MULTIDISCIPLINARY APPROACH 
A multidisciplinary approach is the collaboration of multiple clinicians and should be considered for 
those with CLBP, as some outcomes require specific interventions.105 For example, a psychologist 
may be best placed to provide interventions to improve psychosocial health through changing 
cognitions and behaviours.105 Moreover, physiotherapists and exercise physiologists should be 
considered for improving physical capacity through exercise training, while an occupational therapist 
could be used to target workplace and daily living contributors to pain and disability.105 Dietary 
advice for individuals with CLBP should be delivered by a dietitian, if adiposity is identified as a 
relevant outcome.106 Pain physicians can coordinate the medical management of the patient to best 
determine which clinicians to utilise, and formalise communication between each.105 Importantly, in 
private practice settings, clinicians should identify the specific outcomes relevant to their patient and 
refer on to the appropriate clinician to target these outcomes as necessary. Ultimately, clinicians 
should engage with a range of health care professionals, including those aforementioned, to establish 
a multidisciplinary care team capable of providing best-practice management of CLBP.
CONCLUSIONS
CLBP is a common condition that has a large societal and individual burden. Pain reduction is an 
important outcome for conservative management of people with CLBP, however it should not be the 
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various factors play a role in pain and disability and that different individuals may be impacted at 
different levels for each domain. This suggests that the CLBP management should be adapted to the 
individual as CLBP can have a detrimental impact on physical, psychological and social health. 
Clinicians should engage in dialogue with patients to determine what aspects of these domains are of 
the most concern. Rather than solely focusing on pain intensity, treatment of CLBP should address 
alternative outcomes that are mutually agreed by the clinician and patient. Therefore, in line with the 
biopsychosocial model, we recommend that clinicians should consider assessing a broad range of 
physical, psychological, social, and health-related quality of life measures in patients with CLBP. We 
recommend, at a minimum, clinicians should include the Oswestry Disability Index (physical), Pain 
Catastrophizing Scale or Tampa Scale of Kinesiophobia (psychological), PROMIS social functioning 
(social) and the SF-12 (health-related quality of life), with additional measures to be based on what is 
deemed relevant for the individual patient. Ultimately, this will enable enhanced clinical decision 
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BMI = body mass index, CBT = cognitive behavioural therapy, CFT = cognitive functional therapy, ICC = intraclass correlation coefficient, LBP = low 
back pain, NA = not available, PNE = pain neuroscience education, PROMIS = Patient Reported Outcomes Measurement Information System
*Validity: correlations of >0.7 are strong, 0.3-0.7 are moderate and <0.3 are weak.167 †Internal consistency: For groups Cronbach α≥0.70 suggested 
(moderate), for individuals Cronbach α≥0.90suggested (strong).154 ‡Test-retest reliability: For groups ICC≥0.70 suggested (moderate), for individuals 
ICC≥0.90 suggested (strong).168 §Minimum clinically meaningful difference is how large a difference needs to be present in a single patient for it to be 
"real".169
aConstuct validity between Oswestry Disability Index and Roland Morris Disability Questionnaire, bConstruct validity between the two long term-disability 
measures, cConstruct validity compared to isokinetic back extensor dynamometry, dValidity of waist circumference and waist-to-hip ratio comparative to 
visceral adipose fat measured by computed tomography, eConstruct validity between the Tampa Scale of Kinesiophobia and Fear-Avoidance beliefs 
questionnaire, fConstruct validity determined against measures including the Roland Morris, Pain Intensity and Fear-Avoidance beliefs questionnaire, 
gConstruct validity comparative to the Positive and Negative Affects scale, hConstruct validity comparative to other sleep scales, iConstuct validity 
compared to physical and mental composite scores of the SF-12, jConstruct validity compared to interviewer methods. 
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